ICYMI - Russia's coronavirus vaccine 92% efficacy (study published in The Lancet)

Russia's Sputnik V vaccine was viewed with scepticism but this is being reassessed following the study published in The Lancet on Tuesday.

  • 92% effective in protecting people from developing COVID-19 symptoms
  • study follows a Phase 3 trial in Moscow hospitals and clinics that included nearly 22,000 participants
  • vaccine known as Gam-COVID-Vac

For more info on the study, link here

And, for the medico brainiacs, link to The Lancet.

Russia's Sputnik V vaccine was viewed with scepticism but this is being reassessed following the study published in The Lancet on Tuesday.

Best in 2026

Sponsored

General Risk Warning
investingLive Premium
Telegram Community
Gain Access